00:42:05 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-07-23 Kvartalsrapport 2024-Q2
2024-05-24 X-dag ordinarie utdelning MNTC 0.00 SEK
2024-05-23 Årsstämma 2024
2024-05-03 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-07-20 Kvartalsrapport 2023-Q2
2023-05-12 X-dag ordinarie utdelning MNTC 0.00 SEK
2023-05-11 Årsstämma 2023
2023-04-27 Kvartalsrapport 2023-Q1
2023-02-03 Bokslutskommuniké 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-07-21 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-28 X-dag ordinarie utdelning MNTC 0.00 SEK
2022-04-27 Årsstämma 2022
2022-02-03 Bokslutskommuniké 2021
2021-10-28 Kvartalsrapport 2021-Q3
2021-07-22 Kvartalsrapport 2021-Q2
2021-05-07 X-dag ordinarie utdelning MNTC 0.00 SEK
2021-05-06 Årsstämma 2021
2021-04-28 Kvartalsrapport 2021-Q1
2021-02-04 Bokslutskommuniké 2020
2020-11-12 Kvartalsrapport 2020-Q3
2020-08-13 Kvartalsrapport 2020-Q2
2020-05-28 X-dag ordinarie utdelning MNTC 0.00 SEK
2020-05-27 Årsstämma 2020
2020-05-14 Kvartalsrapport 2020-Q1
2020-02-27 Bokslutskommuniké 2019
2019-11-25 Kvartalsrapport 2019-Q3
2019-08-29 Kvartalsrapport 2019-Q2
2019-08-28 Extra Bolagsstämma 2019

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Mentice är verksamt inom medicinteknik. Bolaget utvecklar medicinska instrument för endovaskulär simulering samt för träningstillfällen inom kirurgi. Programmen är utvecklade för att användas i utbildningssyfte bland sjukhus och institut. Störst verksamhet återfinns inom Nordamerika och Europa. Utöver huvudverksamheten erbjuds möjligheter till leasing, support, samt teknisk service. Huvudkontoret ligger i Göteborg.
2024-05-21 19:00:00

The Board of Directors of Mentice AB (publ) has today agreed with CEO Göran Malmberg, who recently turned 65, that he will leave his position as CEO. Göran Malmberg will remain in his position until a successor is in place and will also be associated with Mentice AB as a senior advisor during the period after a new CEO has been appointed. The recruitment of Göran Malmberg's successor will begin immediately.

Göran Malmberg has been CEO of Mentice AB since 2008.

"Göran has done an admirable job of first taking Mentice out of the deep crisis the company was in when he took office and then building Mentice into what it is today with technically very advanced and market-leading products in its market segment, an M&S organization with global market subscription that has resulted in an increased market share and rapid sales growth, an average of 22% growth over the last three years and, perhaps most importantly, built an organization on three continents with a very high level of expertise. The Board is pleased and thinks it is valuable for the company that Göran wants to take on an advisory role after he steps down as CEO," says Chairman of the Board Magnus Nilsson.


Göran Malmberg will remain in his role until his successor is in place.

"It has been a demanding and hard-working but also very exciting, fun and challenging time at Mentice. We have managed to build the company to become competitive, a world leader in its niche and well-equipped for continued good growth. I will, together with all the fantastic employees, continue the work of building Mentice until my successor is in place, and I am convinced that the company will have a bright and exciting future. This is beneficial not only for the shareholders but also for the increasing number of patients who ultimately benefit from increased use of Mentice products," says Göran Malmberg.


The recruitment of Göran Malmberg's successor will begin immediately.



For further information, please contact:

Magnus Nilsson, Chairman of the Board, Mentice AB
Email: magnushlnilsson@gmail.com
Telephone +46 708 22 80 61